FAAH and renal cell adenocarcinoma: Combined use of fatty acid amide hydrolase (FAAH) inhibitor URB597 and ferroptosis inducer (1 S,3R)-RLS3 shows strong synergetic inhibition of RCC through induction of G1 cell cycle arrest and promotion of ROS.